Overview

Clinical Study of ATTR-CM

Status:
Recruiting
Trial end date:
2031-07-01
Target enrollment:
Participant gender:
Summary
In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.
Phase:
Phase 4
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University